Abstract:Background: Protein drugs are commonly admixed with organic solvents in traditional fabrication process of sustained release system, which denatures the proteins. Coaxial electrospinning method may reduce the contact between proteins and organic solvents, and is expected to improve the bioactivity of proteins and become a new type drug release system. Objective: To investigate the feasibility of encapsulating protein drug of nerve growth factor (NGF) into the core-shell nanofibers through coaxial electrospinning for sustained release. Design, time and setting: Comparative observation experiments were performed in the Institute of Biological Sciences and Biotechnology, Donghua University (Shanghai, China) from July to December in 2007. Materials: Poly(L-lactide-co-epsilon-caprolactone) [P(LLA-CL), 50:50, Mw=378, 839 g/mol, Mw/Mw=2.732 4] was supplied from Institute of Biological Sciences and Biotechnology, Donghua University (China). Recombinant rat β -NGF was supplied from R&D Systems (USA). Bovine serum albumin (BSA) was purchased from Sigma-Aldrich Inc (USA). Rat pheochromocytoma cell line (PC 12 cells) was obtained from the Cell Bank of Chinese Academy of Sciences (China). Methods: The core-shell structured composite nanofibers with P(LLA-CL) as a shell and BSA/NGF as a core were fabricated through coaxial electrospinning technology. The nanofibers were released in vitro for 8 weeks, and at various time points, the NGF supernatant from the P(LLA-CL)/BSA/NGF fibers was added into serum-free RPMI medium to culture PC12 cells. The nanofibers were divided into three groups according to the core solution flow rate: 0. 10, 0. 15 and 0.25 mL/h. Main outcome measures: Through the images of scanning electron microscopy and transmission electron microscopy, we obtained morphological characters of the nanofibers. The diameter range of the fabricated nanofibers was measured using an image visualization software Image-J. PC 12 cells, which differentiated to neuronal phenotype in the presence of bioactive NGF, were used to test the bioactivity of the NGF released from the electrospun fibers. Results: The core-shell structure of P(LLA-CL)/BSA/NGF nanofibers was achieved by coaxial electrospinning, and the average diameter and diameter range of the nanofibers were increased with the increase of the core solution flow rate. When the core solution flow rate was low as 0.10 or 0.15 mL/h, P(LLA-CL)/BSA/NGF compound had better electrospinnability than the rate was 0.25 mL/h, obtaining the stable and completely "bead-free" nanofibers. PC12 cells could differentiate into neurons and outgrowth neurites in the NGF supernatant from P(LLA-CL)/BSA/NGF nanofibers. It indicated that the released NGF retained some degree of bioactivity for at least 8 weeks. Conclusion: It is feasible to encapsulate protein drug NGF into core-shell nanofibers through coaxial electrospinning technology for sustained release.

Nanoparticles vs. nanofibers: a comparison of two drug delivery systems on assessing drug release performance in vitro

Potential of alginate fibers incorporated with drug-loaded nanocapsules as drug delivery systems

Encapsulating Drugs in Biodegradable Ultrafine Fibers Through Co-Axial Electrospinning

Conventional Electrospinning Vs. Emulsion Electrospinning: A Comparative Study on the Development of Nanofibrous Drug/Biomolecule Delivery Vehicles

Emulsion Electrospinning of Nanofibrous Delivery Vehicles for the Controlled Release of Biomolecules and the in Vitro Release Behaviour of Biomolecules

Nanofiber Prepared by Intermittent Electrospun as Controlled Drug Delivery

Encapsulation of Drug Reservoirs in Fibers by Emulsion Electrospinning: Morphology Characterization and Preliminary Release Assessment

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles

A Review for the Synthesis of Silk Fibroin Nanoparticles with Different Techniques and Their Ability to be Used for Drug Delivery

Strategies For Delivering Bioactive Molecules In Electrospun Fibers

Novel Controlled Drug Delivery System for Multiple Drugs Based on Electrospun Nanofibers Containing Nanomicelles

Preparation of coaxial electrospinning nanofibers for nerve growth factor delivery

Poly (N-Isopropylacrylamide)/poly (ethylene Oxide) Blend Nanofibrous Scaffolds: Thermo-responsive Carrier for Controlled Drug Release

Preparation and Characterization of Electrospun PLGA-SF Nanofibers As a Potential Drug Delivery System

Preparation of the Protein/Polyphenylboronic Acid Nanospheres for Drug Loading and Unloading

Retracted Article: Preparation and Properties of Polymer Micelle-embedded Nanofibrous Membranes for Dual-drug Co-delivery and Multistep Release

A nanofiber-based drug depot with high drug loading for sustained release

Electrospun composite nanofibers containing nanoparticles for the programmable release of dual drugs

Colloidal Stability of Silk Fibroin Nanoparticles Coated with Cationic Polymer for Effective Drug Delivery

A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles.